Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

LUTREPULSE KIT

GONADORELIN ACETATE

Standard Dose
3.2MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LUTREPULSE KIT is listed in Drugs@FDA under application 019687 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient GONADORELIN ACETATE Form and strength INJECTABLE;INJECTION - 3.2MG/VIAL Sponsor FERRING Submission history Latest submission status date: 1993-12-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview LUTREPULSE KIT is listed in Drugs@FDA under application 019687 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GONADORELIN ACETATE Form and strength INJECTABLE;INJECTION - 3.2MG/VIAL Sponsor FERRING Submission history Latest submission status date: 1993-12-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.